Functional anatomy of the sacroiliac joint
The sacroiliac joint complex (SIJC) is described as a diarthrodial, synovial joint associated with a posterior ligamentous network. It receives both anterior innervation from the lumbosacral plexus and posterior sensory innervation via the posterior sacral network (PSN). This dual innervation underpins the concept that both intra-articular and extra-articular structures, including posterior ligaments, can contribute to sacroiliac region pain. Histological and anatomical work has verified the presence of nerve fibers within the joint capsule and adjoining ligaments, supporting the SIJC as a potential nociceptive source.
The posterior sacral network is composed of the lateral branches of the S1–S3 posterior rami, with variable contributions from the S4 lateral branch and the L5 dorsal ramus. These lateral branches traverse the dorsal sacrum and supply the posterior sacroiliac ligaments and the posterior aspect of the joint. Cadaveric studies have mapped these branches and demonstrated substantial anatomic variability in their course, which has direct implications for both diagnostic blocks and radiofrequency lesion placement.
From an innervation standpoint, the sacroiliac joint is thought to receive contributions from the ventral rami of L4 and L5, the dorsal rami of L5, S1, S2, and S3, as well as the superior gluteal nerve. Sacral lateral branch neurotomy specifically addresses the posterior sacroiliac structures, including the posterior joint and associated ligaments, but does not affect ventral innervation, which is considered inaccessible for denervation. This partial denervation concept is important when interpreting clinical responses to radiofrequency procedures.
Anatomical comparison of different radiofrequency ablation techniques has shown that lesion geometry relative to the course of the lateral branches is critical. In a cadaveric analysis of multiple sacroiliac joint radiofrequency strategies, bipolar palisade or strip-lesion techniques captured a greater percentage of lateral branches than traditional monopolar approaches, which are limited by smaller lesion size. Additional work has suggested that a periforaminal conventional monopolar technique may achieve complete neural capture in as few as 12.5% of specimens, whereas larger bipolar strip lesions can theoretically capture more than 95% of the PSN. These anatomical data underpin the evolution of contemporary sacral lateral branch radiofrequency protocols.
Pain mechanisms and diagnosis
Low back pain is highly prevalent, and nociception arising from the sacroiliac joint complex has been estimated to account for a substantial subset of cases. Histological analysis has confirmed nerve fibers within the sacroiliac joint capsule and adjoining ligaments, supporting the joint and its supporting structures as potential generators of pain. Posterior sacroiliac structures innervated by the lateral sacral branches are specifically targeted in sacral lateral branch neurotomy, reflecting the recognition that pain may arise from both intra-articular and periarticular tissues.
Clinical diagnosis of sacroiliac joint pain relies on a combination of physical examination and image-guided diagnostic procedures. A best-practice summary emphasizes the use of multiple provocative maneuvers, including distraction, side thigh thrust, Gaenslen, compression, and sacral thrust tests. The predictive value is greatest when at least two of four selected tests reproduce the patient’s typical pain, whereas the absence of pain reproduction with all six commonly used provocation tests makes sacroiliac pathology unlikely. Additional maneuvers such as Ober’s and Patrick’s tests are considered secondary options but have been less extensively studied.
Imaging plays a supportive, rather than definitive, role in diagnosis. Prior to radiofrequency treatment of the lateral sacral nerves, other potential etiologies of low back and pelvic pain should be evaluated with imaging. Radiographs may demonstrate degenerative changes or inflammation within the sacroiliac joint, but such findings are not considered diagnostic for sacroiliac joint pain. Consequently, image-guided diagnostic blocks have become central to confirming the sacroiliac joint complex as the primary pain source.
Diagnostic blocks can target either the intra-articular space or the posterior sacral network. Multi-site, multi-depth sacral lateral branch blocks have been shown to effectively anesthetize the sacroiliac joint complex, supporting their use as a prognostic tool for sacral lateral branch radiofrequency neurotomy. A best-practice summary recommends that, even when prior intra-articular sacroiliac joint injections have been performed, a diagnostic block of the lateral sacral branches is highly advisable before proceeding to radiofrequency treatment, with a suggested threshold of at least 50% pain reduction to consider the block positive. These diagnostic strategies aim to improve patient selection and predict response to interventional denervation procedures.
Conservative vs interventional treatment
Patients enrolled in interventional trials for sacroiliac joint complex pain are typically required to have persistent symptoms despite a period of conservative management. In the COBRA-SIJ protocol, eligible participants must have at least three months of low back pain attributable to the sacroiliac joint complex and must have failed at least three months of conservative treatment before consideration of radiofrequency ablation. Conservative measures are not detailed in that protocol, but the requirement underscores that radiofrequency neurotomy is positioned as a treatment for chronic, recalcitrant pain rather than first-line therapy.
Image-guided intra-articular sacroiliac joint injections with local anesthetic, with or without corticosteroid, serve both diagnostic and therapeutic roles. Over time, these injections have evolved from blind techniques to fluoroscopically guided procedures, improving accuracy. However, therapeutic intra-articular injections generally provide only temporary relief for most patients, and recurrent symptoms have driven the development of more durable interventional options.
For patients with persistent sacroiliac joint pain despite conservative care and injections, several interventional strategies have been explored. These include radiofrequency ablation of the posterior sacral network, percutaneous cryoneurolysis, chemical neurolysis of the lateral branches of the sacral dorsal rami, endoscopic radiofrequency treatment of the sacroiliac joint complex, and MR-guided high-frequency ultrasound ablation. These modalities share the goal of disrupting nociceptive input from the sacroiliac joint complex, but they differ in mechanism, technical demands, and evidence base.
Among these options, sacral lateral branch radiofrequency neurotomy has emerged as a widely used and systematically studied technique. A systematic review of posterior sacroiliac complex pain management reported that 32–89% of patients undergoing some form of posterior sacral network ablation achieved at least 50% pain relief for six months, and 11–44% achieved complete relief over the same period. Although patient selection and procedural heterogeneity contribute to the variability in outcomes, these data support radiofrequency neurotomy as a key interventional option when conservative measures are insufficient.
Indications for radiofrequency
Indications for sacral lateral branch radiofrequency neurotomy are grounded in chronicity of symptoms, failure of conservative care, and confirmatory diagnostic testing. In the COBRA-SIJ trial, adults aged 18–90 years with at least three months of low back pain attributable to the sacroiliac joint complex, who had not responded to at least three months of conservative treatment and who reported a baseline 7‑day average pain score of at least 4/10, were considered for inclusion. These criteria reflect a focus on chronic, functionally significant pain.
A critical indication for proceeding to radiofrequency ablation is a robust response to diagnostic blocks. The COBRA-SIJ protocol requires at least 50% pain relief following both a fluoroscopically guided intra-articular sacroiliac joint injection with local anesthetic and a fluoroscopically guided posterior sacral network block, or following dual posterior sacral network blocks. A best-practice summary similarly recommends that candidates for lateral sacral branch radiofrequency neurotomy demonstrate at least 50% pain reduction after diagnostic lateral branch blocks, even if they have previously undergone intra-articular injections.
Consensus statements indicate that lateral sacral branch radiofrequency neurotomy may be used for treatment of posterior sacral ligament and joint pain in patients who have a positive response to appropriately placed diagnostic blocks, with a reported evidence grade of II‑1 B. This framing emphasizes that radiofrequency neurotomy is intended for patients in whom the posterior sacroiliac structures have been confirmed as the primary pain source. Additionally, prior systematic review data showing substantial rates of clinically meaningful pain relief after posterior sacral network ablation support its use in carefully selected individuals.
Contraindications to radiofrequency neurotomy must also be considered when determining indications. Reported contraindications include sacral fracture, tumor, radiculopathy, infection, and coagulopathy. In the COBRA-SIJ protocol, further exclusion criteria include prior sacroiliac joint fusion, prior sacroiliac joint radiofrequency procedures, symptomatic hip osteoarthritis, active lumbar radicular pain, evidence of hardware loosening after lumbar or lumbosacral fusion, chronic widespread pain or somatoform disorders, high-dose opioid use, and recent or active infection. These factors delineate a population in whom radiofrequency neurotomy is both technically feasible and clinically appropriate.
Clinical protocols and expected outcomes
Clinical protocols for sacral lateral branch radiofrequency neurotomy are shaped by anatomical studies and comparative evaluations of lesioning strategies. Because of the variability in the course of the posterior lateral sacral branches, monopolar lesions may not reliably capture the target nerves, prompting the development of cooled and bipolar radiofrequency techniques that create larger lesions. Cadaveric work has demonstrated that bipolar palisade techniques capture a greater percentage of lateral branches than traditional monopolar approaches, and that palisade lesion placement is particularly effective in encompassing the posterior sacral network.
Best-practice recommendations for procedural technique emphasize the use of bipolar or cooled radiofrequency to ensure capture of the lateral branches with a larger lesion. A suggested approach is to place six cannulae under lateral fluoroscopic guidance, starting superior to S1 and ending inferior to S3, with the cannulae parallel to each other, spaced 10–12 mm apart, and perpendicular to the sacral surface. When monopolar radiofrequency is used, multiple cannula passes or periforaminal techniques are recommended to increase the effective lesion size. For both bipolar and monopolar procedures, a temperature of 80°C for 60–90 seconds per cycle has been recommended.
Expected outcomes following posterior sacral network ablation have been summarized in systematic reviews and clinical series. A systematic review of posterior sacroiliac complex pain management reported that 32–89% of patients achieved at least 50% pain relief for six months after some form of posterior sacral network ablation, and 11–44% achieved complete pain relief over the same period. Additional observational and controlled studies of unipolar, bipolar, cooled, and pulsed radiofrequency techniques have generally supported the clinical efficacy of these modalities, although the overall quality of evidence has been characterized as fair and heterogeneous.
Specific radiofrequency modalities have also been evaluated in defined patient populations. For example, cooled radiofrequency ablation of the sacroiliac joint region has been associated with a substantial proportion of patients achieving at least 50% pain reduction at follow-up intervals up to 12 months, with some reporting complete relief. In another series, 61% of patients treated with cooled radiofrequency reported at least 50% pain relief for more than four months. Across studies, improvements in pain are often accompanied by gains in physical function and patient-reported global impression of change, although variability in patient selection and technique complicates direct comparison between protocols.
Patient selection criteria
Patient selection for sacral lateral branch radiofrequency neurotomy integrates clinical assessment, imaging, and diagnostic block response. In the COBRA-SIJ randomized trial protocol, inclusion criteria specify adults aged 18–90 years with at least three months of low back pain attributed to the sacroiliac joint complex, a 7‑day average pain score of at least 4/10, and failure of at least three months of conservative treatment. These criteria ensure that candidates have chronic, clinically significant pain that has not responded to non-interventional measures.
A key component of selection is the requirement for substantial pain relief following diagnostic procedures. The COBRA-SIJ protocol mandates at least 50% pain relief after both a fluoroscopically guided intra-articular sacroiliac joint injection with local anesthetic and a fluoroscopically guided posterior sacral network block, or after dual posterior sacral network blocks. A pain diary with categorical relief levels (including 100% and 80–99% relief) is used to document the response, and the treating physician reviews this diary to determine eligibility.
Best-practice recommendations further support the use of diagnostic lateral sacral branch blocks as a prognostic tool. A diagnostic block of the lateral sacral branches is highly recommended prior to radiofrequency neurotomy, with a suggested cutoff of at least 50% pain reduction to proceed. Multi-site, multi-depth techniques are advised to improve the likelihood of anesthetizing the posterior sacral network and to enhance the predictive value of the block. These strategies aim to identify patients whose pain arises predominantly from posterior sacroiliac structures targeted by radiofrequency.
Exclusion criteria help refine patient selection by identifying conditions that may confound outcomes or increase risk. In the COBRA-SIJ protocol, exclusions include prior sacroiliac joint fusion, prior sacroiliac joint radiofrequency procedures, symptomatic hip osteoarthritis, active lumbar radicular pain, evidence of hardware loosening after lumbar or lumbosacral fusion, chronic widespread pain or somatoform disorders, high-dose opioid use, and recent or active infection. Additional contraindications to radiofrequency neurotomy include sacral fracture, tumor, radiculopathy, infection, and coagulopathy. Collectively, these criteria define a population in whom sacral lateral branch radiofrequency neurotomy is most likely to be both safe and clinically beneficial.
Sources (Bibliography)
- Conventional or Bipolar Radiofrequency Ablation for the Treatment of Sacroiliac Joint Pain? The COBRA-SIJ study, a Double-blind, Randomized, Comparative Trial. 2023.
- Stratus UofU Conger SIJ RFA Clinical Trial Agreement Signed. Conventional or Bipolar Radiofrequency Ablation for the Treatment of Sacroiliac Joint Pain? Results of the COBRA-SIJ study, a Double-blinded, Randomized, Comparative Trial.
- Latest Evidence Based Application for Radiofrequency Neurotomy. Journal of Pain Research, 2021.
- MIS Pain V2 Radiofrequency Ablation Using a Novel Multitined, Wright, Allen, Craft and Holley. 2012